Erg protein inhibitor (University of British Columbia)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameErg protein inhibitor (University of British Columbia)
Drug Alias NameVPC-18005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscriptional regulator ERG degraders
TargetsTranscriptional regulator ERG
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A